Prostate Cancer Survival Rates by Age The older you get, the more likely you are to develop prostate cancer. Here's how often it's diagnosed among those in different age groups: Under 50: 1 in every 456 Age 50-59: 1 in 54 Age 60-69: 1 in 19 ...
In contrast, once metastasis has been detected by imaging, the vast majority of patients will likely die from prostate cancer. Over the past two decades, serum PSA screening has provided a valuable tool for prostate cancer surveillance, however the age-adjusted incidence of mortality has remained ...
Reliable prognostic biomarkers to distinguish indolent from aggressive prostate cancer (PCa) are lacking. Many studies investigated microRNAs (miRs) as PCa prognostic biomarkers, often reporting inconsistent findings. We present a systematic review of these; also systematic reanalysis of public miR-profile...
963 to 200 and Severe Pains Vanished.This is the story of a 72-year-old man from Surabaya, Indonesia. His prostate cancer had spread extensively to his back bone. I have the opportunity to meet with this patient in his house when we visited Surabaya. He benefited...
Prostate Cancer Key Statistics
ContextSexual activity has been hypothesized to play a role in the development of prostate cancer, but epidemiological data are virtually limited to
While the 5-year survival rate for local and regional prostate cancer is nearly 100%, it decreases dramatically for advanced tumours. Accessibility to health care is an important factor for cancer prognosis. The U.S. Military Health System (MHS) provides
Prostate cancer is a common malignant tumor in elderly men in western countries. In the past decade, the incidence and mortality of prostate cancer in China have shown a rapid upward trend. With the changes of social economy, life style and the progress of diagnosis and treatment, the epidemio...
Genetic testing, to identify pathogenic or likely pathogenic variants in prostate cancer, is valuable in guiding treatment decisions for men with prostate cancer and to inform cancer prevention and early detection options for their immediate blood relati
Prostate cancer (PC) is a leading cause of death in older men. Androgen deprivation therapy (ADT) is considered the standard-of-care for men with locally advanced disease. However, continuous androgen ablation is associated with acute and long-term adver